Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Ustekinumab 90mg/ml Syr (CDM 63600618) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 30, 2026 , from http://ppman.hank.ai/transparency/procedure/63600618/by-state?code_type=CDM
“Ustekinumab 90mg/ml Syr (CDM 63600618) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/63600618/by-state?code_type=CDM. Accessed
June 30, 2026 .
“Ustekinumab 90mg/ml Syr (CDM 63600618) by State,” HANK Price Transparency ,
accessed June 30, 2026 ,
http://ppman.hank.ai/transparency/procedure/63600618/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
63600618 — Ustekinumab 90mg/ml Syr
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$58,586
National median
$44,733 – $69,024
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 63600618 (CDM), with interquartile range
State Median p25 p75
NC $58,586 $44,733 $69,024